|
TMEM167A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.647800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.662400E-01 |
| Normal-vs-Stage2 |
4.659000E-01 |
| Normal-vs-Stage3 |
2.360800E-01 |
| Normal-vs-Stage4 |
4.013000E-01 |
| Stage1-vs-Stage2 |
3.016200E-01 |
| Stage1-vs-Stage3 |
1.698620E-01 |
| Stage1-vs-Stage4 |
1.778820E-01 |
| Stage2-vs-Stage3 |
6.662600E-01 |
| Stage2-vs-Stage4 |
6.697200E-01 |
| Stage3-vs-Stage4 |
9.647600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.892400E-01 |
| Normal-vs-AfricanAmerican |
6.280800E-01 |
| Normal-vs-Asian |
2.858600E-01 |
| Caucasian-vs-AfricanAmerican |
8.476800E-01 |
| Caucasian-vs-Asian |
8.917700E-02 |
| AfricanAmerican-vs-Asian |
3.301200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.212000E-01 |
| Normal-vs-Female |
5.950200E-02 |
| Male-vs-Female |
4.822000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.516800E-01 |
| Normal-vs-Extreme_Weight |
7.719600E-01 |
| Normal-vs-Obese |
4.587200E-01 |
| Normal-vs-Extreme_Obese |
6.910200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.946400E-01 |
| Normal_Weight-vs-Obese |
5.673600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.888400E-01 |
| Extreme_Weight-vs-Obese |
3.812400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.108800E-01 |
| Obese-vs-Extreme_Obese |
5.206800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.102000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.538300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.541400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.995400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.991000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.748200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.699790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.838700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.347600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.220000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.845440E-01 |
| Normal-VS-Type2 PRCC |
5.315600E-01 |
| Normal-VS-KIRP CIMP |
2.858000E-01 |
| Normal-VS-Unclassified PRCC |
8.597600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.239840E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.023200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.761800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.312200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.741200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.243800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.328200E-01 |
| Normal-vs-N1 |
2.154400E-01 |
| Normal-vs-N2 |
4.227400E-01 |
| N0-vs-N1 |
1.901980E-01 |
| N0-vs-N2 |
3.078200E-01 |
| N1-vs-N2 |
9.088400E-01 |
|
|
